Alaunos Therapeutics

TCRTNasdaq United States Health Care Biotechnology: Pharmaceutical Preparations

Market cap

$3.226 M

$1.27 +0.79%

Close of 22 Sept 2026

Revenue

$5.00K

#3631 by revenue

Earnings

-$4.18M

Loss-making

Shares outstanding

2,540,480

Latest filing cover page

P/E ratio

—

Cap ÷ net income

Biotechnology: Pharmaceutical Preparations, ranked by market cap

All 499 →

#482RedHill BiopharmaRDHL$3.29M
#483China SXT PharmaceuticalsSXTC$3.26M
#484Alaunos TherapeuticsTCRT$3.23M
#485Silo PharmaSILO$3.02M
#486OnconetixONCO$2.99M

What if Alaunos Therapeutics were worth as much as…

Open the what-if tool →

Gold $30.2T

$11,900,887

Per share 9,370,777× higher

Bitcoin $1.74T

$685,561.33

Per share 539,812× higher

Nvidia $5.52T

$2,171,151

Per share 1,709,568× higher

Or at a round number

$5.00M $10.0M $20.0M $50.0M

Where these numbers come from

Share counts and financials for Alaunos Therapeutics are taken from its own SEC filings via EDGAR: public record, not an estimate. Market cap is shares outstanding multiplied by the latest close. Last updated 23 Sept 2026. Read the methodology.